WA
ENZ

Wealth Alliance’s Enzo Biochem, Inc. ENZ Stock Holding History

Wealth Alliance’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,033
Closed -$20.3K – 536
2023
Q2 		$20.3K Sell
11,033
-400
-3% -$926 ﹤0.01% 505
2023
Q1 		$27.8K Hold
11,433
– – ﹤0.01% 496
2022
Q4 		$16.3K Hold
11,433
– – ﹤0.01% 482
2022
Q3 		$25K Hold
11,433
– – ﹤0.01% 448
2022
Q2 		$24K Buy
+11,433
New +$28.3K ﹤0.01% 434
2020
Q1 		– Sell
-16,400
Closed -$43K – 248
2019
Q4 		$43K Buy
+16,400
New +$49K 0.03% 85

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Wealth Alliance's ENZ Position: Q3 2023 in Review

Wealth Alliance sold out of Enzo Biochem, Inc. (ENZ) in Q3 2023, closing a stake of 11,033 shares — an estimated $20.3K sold.

Wealth Alliance first reported a position in ENZ in Q4 2019 and held it in 6 quarters. The position peaked at $43K in Q4 2019. 39 funds tracked by Wall St. Rank hold ENZ as of Q3 2023.

  • Wealth Alliance reported no remaining Enzo Biochem, Inc. position as of Q3 2023 after selling out during the quarter.
  • Wealth Alliance sold 11,033 Enzo Biochem, Inc. shares in Q3 2023, an estimated $20.3K.
  • Wealth Alliance first reported a position in Enzo Biochem, Inc. in Q4 2019 and held it in 6 quarters.
  • Wealth Alliance's Enzo Biochem, Inc. position peaked at $43K in Q4 2019.
  • 39 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2023.

Based on Wealth Alliance's 13F filing for Q3 2023, filed 9 Nov 2023.